This $250 Million Startup Tracks How Cancer Reacts To Treatment In Real Time

NVision raises $38 million led by health diagnostics giant Abbott to scale up its groundbreaking cancer imaging system. Next up: using its quantum technology to design new drugs.

On a sunny Tuesday in late March at Memorial Sloan…